Medizinische Universität Graz - Research portal
Selected Publication:
Mozes, FE; Kaur, S; Vali, Y; Alzoubi, O; Wong, VWS; Li, GL; Wong, GLHC; Staufer, K; Trauner, M; Paternostro, R; Stauber, RE; Bugianesi, E; Gaia, S; Armandi, A; Lupsor-Platon, M; Sebastiani, G; Mahadeva, S; Rajaram, R; Zheng, MH; George, J; Eslam, MM; Pennisi, G; Aithal, GP; Palaniyappan, N; Lee, D; Nasr, P; Cassinotto, C; De Ledinghen, V; Berzigotti, A; Mendoza, YP; Noureddin, M; Truong, E; Boursier, J; De Saint Loup, M; Hirooka, M; Shima, T; Dr Shalimar; Hagström, SH; Ekstedt, M; Akbari, C; Chan, WK; Tsochatzis, EA; Liguori, A; Petta, S; Vigano, M; Ridolfo, S; Yoneda, M; Nakajima, A; Holleboom, AG; Van Dijk, AM; Mak, AL; Cobbold, JFL; Karlas, T; Wiegand, J; Fournier, C; Martic, M; Tuthill, T; Yunis, C; Anstee, QM; Harrison, S; Bossuyt, P; Pavlides, M.
NASH SEVERITY ASSESSED BY THE NAFLD ACTIVITY SCORE (NAS) DOES NOT ADD PROGNOSTIC INFORMATION TO FIBROSIS STAGE IN PATIENTS WITH NAFLD
HEPATOLOGY. 2023; 78: S1018-S1020.-Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD); NOV 10-14, 2023; Boston, MA.
[Poster]
Web of Science
- Authors Med Uni Graz:
- Stauber Rudolf
- Trauner Michael
- Altmetrics: